According to the research report, the global neurotechnology market size is expected to touch USD 38.17 Billion by 2032, from USD 12.82 Billion in 2022, growing with a significant CAGR of 11.53% from 2022 to 2032.
The neurotechnology market report offers a
comprehensive study of the current state expected at the major drivers, market
strategies, and key vendors’ growth. The report presents energetic visions to
conclude and study the market size, market hopes, and competitive surroundings.
The research also focuses on the important achievements of the market, research
& development, and regional growth of the leading competitors operating in
the market. The current trends of the global neurotechnology market in
conjunction with the geographical landscape of this vertical have also been
included in this report.
The report offers intricate dynamics about
different aspects of the global neurotechnology market, which aids companies
operating in the market in making strategic development decisions. The study
also elaborates on significant changes that are highly anticipated to configure
growth of the global neurotechnology market during the forecast period. It also
includes a key indicator assessment that highlights growth prospects of this
market and estimates statistics related to growth of the market in terms of
value (US$ Mn) and volume (tons).
Sample Link @ https://www.precedenceresearch.com/sample/2499
| Report Coverage | Details |
| Market Size in 2022 | USD 12.82 Billion |
| Market Size by 2032 | USD 38.17 Billion |
| Growth Rate from 2023 to 2032 | CAGR of 11.53% |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Segments Covered | By Product Type, By Conditions, By End-Use |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America and Middle East & Africa |
This study covers a detailed segmentation of the global neurotechnology market, along with key information and a competition outlook. The report mentions company profiles of players that are currently dominating the global neurotechnology market, wherein various developments, expansions, and winning strategies practiced and implemented by leading players have been presented in detail.
Market Segmentation
- Neurostimulation
- Deep Brain Stimulator
- Spinal Cord Stimulator
- Gastric Electric Stimulator
- Vagus Nerve Stimulator
- Sacral Nerve Stimulator
- Transcutaneous Electrical Nerve Stimulation (TENS)
- Others
- Neurosensing
- Neuroprostheses
- Neurorehabilitation
By Conditions
- Cognitive Disorders
- Pain Treatment
- Urinary and Fecal Incontinence
- Epilepsy
- Parkinson's disease
- Hearing Conditions
- Sleep Disorder
- Depression
- Others
By End-Use
- Ambulatory surgical centers
- Hospitals
- Homecare facilities
- Others
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa (MEA)
Research Methodology
The research methodology adopted by
analysts for compiling the global neurotechnology market report is based on
detailed primary as well as secondary research. With the help of in-depth
insights of the market-affiliated information that is obtained and legitimated
by market-admissible resources, analysts have offered riveting observations and
authentic forecasts for the global market.
During the primary research phase, analysts
interviewed market stakeholders, investors, brand managers, vice presidents,
and sales and marketing managers. Based on data obtained through interviews of
genuine resources, analysts have emphasized the changing scenario of the global
market.
For secondary research, analysts
scrutinized numerous annual report publications, white papers, market
association publications, and company websites to obtain the necessary
understanding of the global neurotechnology market.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Neurotechnology Market
5.1. COVID-19 Landscape: Neurotechnology Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Neurotechnology Market, By Product Type
8.1. Neurotechnology Market, by Product Type, 2022-2032
8.1.1 Neurostimulation
8.1.1.1. Market Revenue and Forecast (2022-2032)
8.1.2. Neurosensing
8.1.2.1. Market Revenue and Forecast (2022-2032)
8.1.3. Neuroprostheses
8.1.3.1. Market Revenue and Forecast (2022-2032)
8.1.4. Neurorehabilitation
8.1.4.1. Market Revenue and Forecast (2022-2032)
Chapter 9. Global Neurotechnology Market, By Conditions
9.1. Neurotechnology Market, by Conditions, 2022-2032
9.1.1. Cognitive Disorders
9.1.1.1. Market Revenue and Forecast (2022-2032)
9.1.2. Pain Treatment
9.1.2.1. Market Revenue and Forecast (2022-2032)
9.1.3. Urinary and Fecal Incontinence
9.1.3.1. Market Revenue and Forecast (2022-2032)
9.1.4. Epilepsy
9.1.4.1. Market Revenue and Forecast (2022-2032)
9.1.5. Parkinson's disease
9.1.5.1. Market Revenue and Forecast (2022-2032)
9.1.6. Hearing Conditions
9.1.6.1. Market Revenue and Forecast (2022-2032)
9.1.7. Sleep Disorder
9.1.7.1. Market Revenue and Forecast (2022-2032)
9.1.8. Depression
9.1.8.1. Market Revenue and Forecast (2022-2032)
9.1.9. Others
9.1.9.1. Market Revenue and Forecast (2022-2032)
Chapter 10. Global Neurotechnology Market, By End-Use
10.1. Neurotechnology Market, by End-Use, 2022-2032
10.1.1. Ambulatory surgical centers
10.1.1.1. Market Revenue and Forecast (2022-2032)
10.1.2. Hospitals
10.1.2.1. Market Revenue and Forecast (2022-2032)
10.1.3. Homecare facilities
10.1.3.1. Market Revenue and Forecast (2022-2032)
10.1.4. Others
10.1.4.1. Market Revenue and Forecast (2022-2032)
Chapter 11. Global Neurotechnology Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Product Type (2022-2032)
11.1.2. Market Revenue and Forecast, by Conditions (2022-2032)
11.1.3. Market Revenue and Forecast, by End-Use (2022-2032)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Product Type (2022-2032)
11.1.4.2. Market Revenue and Forecast, by Conditions (2022-2032)
11.1.4.3. Market Revenue and Forecast, by End-Use (2022-2032)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Product Type (2022-2032)
11.1.5.2. Market Revenue and Forecast, by Conditions (2022-2032)
11.1.5.3. Market Revenue and Forecast, by End-Use (2022-2032)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product Type (2022-2032)
11.2.2. Market Revenue and Forecast, by Conditions (2022-2032)
11.2.3. Market Revenue and Forecast, by End-Use (2022-2032)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Product Type (2022-2032)
11.2.4.2. Market Revenue and Forecast, by Conditions (2022-2032)
11.2.4.3. Market Revenue and Forecast, by End-Use (2022-2032)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Product Type (2022-2032)
11.2.5.2. Market Revenue and Forecast, by Conditions (2022-2032)
11.2.5.3. Market Revenue and Forecast, by End-Use (2022-2032)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Product Type (2022-2032)
11.2.6.2. Market Revenue and Forecast, by Conditions (2022-2032)
11.2.6.3. Market Revenue and Forecast, by End-Use (2022-2032)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Product Type (2022-2032)
11.2.7.2. Market Revenue and Forecast, by Conditions (2022-2032)
11.2.7.3. Market Revenue and Forecast, by End-Use (2022-2032)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product Type (2022-2032)
11.3.2. Market Revenue and Forecast, by Conditions (2022-2032)
11.3.3. Market Revenue and Forecast, by End-Use (2022-2032)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Product Type (2022-2032)
11.3.4.2. Market Revenue and Forecast, by Conditions (2022-2032)
11.3.4.3. Market Revenue and Forecast, by End-Use (2022-2032)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Product Type (2022-2032)
11.3.5.2. Market Revenue and Forecast, by Conditions (2022-2032)
11.3.5.3. Market Revenue and Forecast, by End-Use (2022-2032)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Product Type (2022-2032)
11.3.6.2. Market Revenue and Forecast, by Conditions (2022-2032)
11.3.6.3. Market Revenue and Forecast, by End-Use (2022-2032)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Product Type (2022-2032)
11.3.7.2. Market Revenue and Forecast, by Conditions (2022-2032)
11.3.7.3. Market Revenue and Forecast, by End-Use (2022-2032)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product Type (2022-2032)
11.4.2. Market Revenue and Forecast, by Conditions (2022-2032)
11.4.3. Market Revenue and Forecast, by End-Use (2022-2032)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Product Type (2022-2032)
11.4.4.2. Market Revenue and Forecast, by Conditions (2022-2032)
11.4.4.3. Market Revenue and Forecast, by End-Use (2022-2032)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Product Type (2022-2032)
11.4.5.2. Market Revenue and Forecast, by Conditions (2022-2032)
11.4.5.3. Market Revenue and Forecast, by End-Use (2022-2032)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Product Type (2022-2032)
11.4.6.2. Market Revenue and Forecast, by Conditions (2022-2032)
11.4.6.3. Market Revenue and Forecast, by End-Use (2022-2032)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Product Type (2022-2032)
11.4.7.2. Market Revenue and Forecast, by Conditions (2022-2032)
11.4.7.3. Market Revenue and Forecast, by End-Use (2022-2032)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Product Type (2022-2032)
11.5.2. Market Revenue and Forecast, by Conditions (2022-2032)
11.5.3. Market Revenue and Forecast, by End-Use (2022-2032)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Product Type (2022-2032)
11.5.4.2. Market Revenue and Forecast, by Conditions (2022-2032)
11.5.4.3. Market Revenue and Forecast, by End-Use (2022-2032)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Product Type (2022-2032)
11.5.5.2. Market Revenue and Forecast, by Conditions (2022-2032)
11.5.5.3. Market Revenue and Forecast, by End-Use (2022-2032)
Chapter 12. Company Profiles
12.1. General Electric Company
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Siemens Healthcare Private Limited
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Shimadzu Corporation
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Koninklijke Philips N.V.
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Hitachi Medical Corporation
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Elekta AB
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Toshiba Medical Systems Corporation
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Tristan Technologies, Inc.
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1
774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
Blog: https://www.pharma-geek.com
0 Comments